dc.contributor.author | Demir, Esra | |
dc.contributor.author | Erol, Vedat Buğra | |
dc.contributor.author | Olmuşçelik, Oktay | |
dc.contributor.author | Koryürek, Özgül M. | |
dc.contributor.author | Tabak, Ömür | |
dc.contributor.author | Demir, Bülent | |
dc.date.accessioned | 2023-01-17T12:53:24Z | |
dc.date.available | 2023-01-17T12:53:24Z | |
dc.date.issued | 2022 | en_US |
dc.identifier.citation | Demir, E., Erol, V. B., Olmuşçelik, O., Koryürek, Ö. M., Tabak, Ö. ve Demir, B. (2022). The relationship between hepatic high FIB-4 score and COVID-19 pneumonia. Clinical Laboratory, 68(3), 539-544. https://dx.doi.org/10.7754/Clin.Lab.2021.210616 | en_US |
dc.identifier.issn | 1433-6510 | |
dc.identifier.uri | https://dx.doi.org/10.7754/Clin.Lab.2021.210616 | |
dc.identifier.uri | https://hdl.handle.net/20.500.12511/10322 | |
dc.description.abstract | Background: We aimed to compare the level of hepatic FIB-4 scores between COVID-19 patients who had pneu-monia and COVID-19 patients who had no pneumonia in an attempt to develop a risk assessment after the treat-ment and recovery of active COVID-19 infection. Methods: The study included 80 patients who were consecutively selected and admitted to an internal medicine outpatient clinic for a control examination after COVID-19 infection. Chest tomography was performed on all pa-tients during the COVID-19 infection. Patients were divided into two groups as those with and without lung in-volvement on CT. COVID-19 infection was diagnosed using real-time reverse transcription-polymerase chain re-action (RT-PCR). The hepatic fibrosis 4 (FIB-4) index score was calculated for each patient. The statistical ana-lyses were performed using Student's t-test and chi-squared tests. Results: We found that the increased hepatic FIB-4 index score in patients with pneumonia group was statistically significant compared to the control group (p < 0.001). The regression analysis showed that the hepatic FIB-4 index has significant prognostic efficiencies in both uni-and multivariate models (p < 0.05). Conclusions: The hepatic FIB-4 index appears to be a simple parameter with a good prognostic value in patients with COVID-19 infection. | en_US |
dc.language.iso | eng | en_US |
dc.publisher | Clinical Laboratory Publication | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | Coronavirus Infections | en_US |
dc.subject | Liver Fibrosis | en_US |
dc.subject | Pneumonia | en_US |
dc.subject | Prognostic Factors | en_US |
dc.title | The relationship between hepatic high FIB-4 score and COVID-19 pneumonia | en_US |
dc.type | article | en_US |
dc.relation.ispartof | Clinical Laboratory | en_US |
dc.department | İstanbul Medipol Üniversitesi, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü, İç Hastalıkları Ana Bilim Dalı | en_US |
dc.authorid | 0000-0002-3793-5251 | en_US |
dc.authorid | 0000-0002-9815-1848 | en_US |
dc.identifier.volume | 68 | en_US |
dc.identifier.issue | 3 | en_US |
dc.identifier.startpage | 539 | en_US |
dc.identifier.endpage | 544 | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.identifier.doi | 10.7754/Clin.Lab.2021.210616 | en_US |
dc.institutionauthor | Demir, Esra | |
dc.institutionauthor | Erol, Vedat Buğra | |
dc.institutionauthor | Olmuşçelik, Oktay | |
dc.identifier.wosquality | Q4 | en_US |
dc.identifier.wos | 000753807200001 | en_US |
dc.identifier.scopus | 2-s2.0-85125839794 | en_US |
dc.identifier.pmid | 35254026 | en_US |
dc.identifier.scopusquality | Q3 | en_US |